(Added to oral) |
(Added Cannabis section and study) |
||
| Line 109: | Line 109: | ||
==Arthritis== | ==Arthritis== | ||
==Auditory== | ==Auditory== | ||
| Line 168: | Line 170: | ||
*Acknowledgements: This work was supported by the Italian Ministry of Instruction, University and Research. | *Acknowledgements: This work was supported by the Italian Ministry of Instruction, University and Research. | ||
*Keywords: nAChR; Dideoxycytidine; Oxaliplatin; Antiviral; Anticancer, pain, chemotherapy, nicotine, neuropathy | *Keywords: nAChR; Dideoxycytidine; Oxaliplatin; Antiviral; Anticancer, pain, chemotherapy, nicotine, neuropathy | ||
==Cannabis / THC== | |||
===2020 [https://pubmed.ncbi.nlm.nih.gov/32034447/ Nicotine patch for cannabis withdrawal symptom relief: a randomized controlled trial]=== | |||
*The findings provide the first evidence that [[Abbreviations|NP (Nicotine Patch)]] may be able to attenuate NA (negative affect) - related withdrawal symptoms in individuals with cannabis use disorder who are not heavy users of tobacco or nicotine. | |||
*[https://sci-hub.se/10.1007/s00213-020-05476-1 PDF Version] | |||
*Citation: Gilbert DG, Rabinovich NE, McDaniel JT. Nicotine patch for cannabis withdrawal symptom relief: a randomized controlled trial. Psychopharmacology (Berl). 2020 May;237(5):1507-1519. doi: 10.1007/s00213-020-05476-1. Epub 2020 Feb 7. PMID: 32034447. | |||
*Acknowledgement: The study was supported by NIH grant R01DA031006 awarded to David Gilbert. | |||
*Keywords: Cannabis; Marijuana; Negative affect; Nicotine; Smoking; THC; Testing effect; Withdrawal symptoms. | |||
==Cognitive / IQ== | ==Cognitive / IQ== | ||
edits